Skip to main content
. 2018 May 2;25(6):819–827. doi: 10.1177/1352458518771875

Figure 1.

Figure 1.

Definitions used for the HRA and HRA + DAT subgroups.

DMD: disease modifying drug; DAT: disease activity on treatment; HRA: high relapse activity; HRA+DAT: high relapse activity plus disease activity on treatment.